GoodRx Holdings Inc
For the period ended Jun 30, 2024. Filed Aug 8, 2024.
View on SEC.govAbout this filing
A company's report for each of its first three quarters. The financial statements are not audited. It shows how the business has moved since the last annual report, and what management says changed.
Jun 30, 2024 · Filed Aug 8, 2024
Extracted filing text, with the paragraph anchors used by the comparison.
See the whole filing, with its images and exhibitsContents
Item 5. Other Information
Insider Trading Arrangements
During the three months ended June 30, 2024, other than as described below for Trevor Bezdek and Douglas Hirsch,
none of our directors or officers (as defined in Section 16 of the Exchange Act), adopted, modified orterminated any
contract, instruction or written plan for the purchase or sale of our securities that was intended to satisfy the affirmative
defense conditions of Rule 10b5-1(c) of the Exchange Act (a "Rule 10b5-1 Trading Plan") or any "non-Rule 10b5-1 trading
arrangement" (as defined in Item 408(c) of Regulation S-K ofthe Exchange Act).
On June 7, 2024, Trevor Bezdek, our Chairman and a director, early terminated his existing Rule 10b5-1 Trading Plan
initially adopted on March 3, 2023 andentered into a modified Rule 10b5-1 Trading Plan (the “Modified Bezdek Plan”),
pursuant to which Mr. Bezdek and a grantor retained annuity trust, of which Mr. Bezdek is the sole trustee and annuitant,
may make periodic sales of up to 2,632,721 shares of our Class A common stock plus an undeterminable number of our
Class A common stock underlying 256,595 unvested restricted stock units to bereceived after giving effect to the number of
shares of Class A common stock surrendered to the Company to cover withholding taxes upon vesting. The Modified
Bezdek Plan will remain in effect until the earlier of (i)June 6, 2025, (ii) the date on which all trades set forth in the Modified
Bezdek Plan have been executed, or (iii) such time as the Modified Bezdek Plan is otherwise terminated according to its
terms.
On June 7, 2024, Douglas Hirsch, our Chief Mission Officer and a director, early terminated his existing Rule 10b5-1
Trading Plan initially adopted on March 3, 2023 andentered into a modified Rule 10b5-1 Trading Plan (the “Modified Hirsch
Plan”), pursuant to which Mr. Hirsch and a grantor retained annuity trust, of which Mr. Hirsch is the sole trustee and
annuitant, may make periodic sales of up to 2,632,721 shares of our Class A common stock plus an undeterminable number
of our Class A common stock underlying 256,595 unvested restricted stock units to bereceived after giving effect to the
number of shares of Class A common stock surrendered to the Company to cover withholding taxes upon vesting. The
Modified Hirsch Plan will remain in effect until the earlier of (i)June 6, 2025, (ii) the date on which all trades set forth in the
Modified Hirsch Plan have been executed, or (iii) such time as the Modified Hirsch Plan is otherwise terminated according to
its terms.
The text of this filing, as the company filed it with the SEC, without its images or exhibits. This is not investment advice.